Imricor Medical Systems, Inc. (ASX:IMR)

Australia · Delayed Price · Currency is AUD

2.150

+0.090 (4.37%)

At close: Feb 27, 2026

47.26% (1Y)

Market Cap	690.04M
Revenue (ttm)	438.23K
Net Income (ttm)	-37.96M
Shares Out	320.95M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	393,842
Average Volume	173,306
Open	2.045
Previous Close	2.060
Day's Range	2.020 - 2.180
52-Week Range	1.115 - 2.250
Beta	0.28
RSI	60.92
Earnings Date	Feb 24, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with except... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2006

Country United States

Stock Exchange Australian Securities Exchange

Ticker Symbol IMR

Full Company Profile

Financial Performance

In 2025, Imricor Medical Systems's revenue was $292,309, a decrease of -69.53% compared to the previous year's $959,424. Losses were -$25.32 million, -14.73% less than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.